Amperos Health announced it has raised $16 million in a Series A round led by Bessemer Venture Partners, with participation from Uncork Capital and Neo, alongside the launch of its AI-native denial management and revenue recovery platform.
The platform is designed to automate the full denial management process for healthcare providers, from payer follow-ups and appeals to claims resubmissions and collections. By combining agentic AI capabilities with human expertise for complex cases, Amperos aims to help providers recover revenue more efficiently while reducing administrative burden.
Amperos said its solution addresses a growing challenge in healthcare revenue cycle management, where denial rates have increased significantly, contributing to hundreds of billions of dollars in lost revenue annually. The company’s platform enables providers to resolve denials up to five times faster and reduce denial rates by as much as 70%, while improving overall recovery outcomes.
To date, Amperos has supported more than 3,000 clinical locations across all 50 states, helping recover nearly $700 million in annual revenue across more than 500,000 claims. The company’s technology leverages large language models across voice, automation, and workflow orchestration to manage end-to-end collections processes without manual handoffs.
The new funding will be used to expand the company’s platform capabilities, enhance analytics, and extend its agentic AI solutions into additional revenue cycle management workflows. Amperos also plans to scale its operations to serve a broader base of healthcare providers.
The company said its approach differs from existing solutions by fully automating the denial management lifecycle, rather than addressing isolated steps such as appeals or payer communications.
KEY QUOTES:
“Complexity in healthcare revenue cycle management (RCM) should not be the norm, and that’s why our mission at Amperos is to streamline the denial and collections process so providers can focus on what matters most – operating their practices and serving their patients. I’m thrilled to announce our most recent funding round, which will be critical as Amperos accelerates its growth to serve more providers, expands its analytics capabilities and launches new agentic capabilities in other RCM workflows.”
Michal Miernowski, Chief Executive Officer And Co-Founder, Amperos Health
“Denials are one of healthcare’s fastest-growing pain points: a growing portion of claims denied, hundreds of billions in lost revenue, and RCM teams that are chronically understaffed. It’s a broken process ripe for AI transformation. What sets Amperos apart is that they’re the first truly agentic AI platform we’ve seen to automate this workflow end-to-end, from portal follow-ups and calls to corrected claims and appeals, with no handoffs and no gaps. We’re excited to see Amperos continue to grow its impact for customers. The results speak for themselves: 22% more recovered per claim at up to 50% lower cost, creating real financial relief for providers who are already operating on razor-thin margins.”
Sofia Guerra, Partner, Bessemer Venture Partners
“Our partnership with Amperos has helped ease the workload that comes with recovering unpaid claims and insurance collections tremendously. By helping my team work through time-consuming tasks faster and focus on more complex needs, we’ve been able to recover 24% more claims without increasing headcount. DOCS Dermatology is a provider-first organization, and Amperos Health ensures that our providers are properly compensated for the care they give.”
Valerie DeCaro, Vice President Of Revenue Cycle Management, DOCS Dermatology
